The allure of the largest U.S. technology companies is understandable given significant returns last year, but their sheer size is the reason for their eventual downfall and long-term stock underperformance, according to Rob Arnott, founder of Research Affiliates.
Shareholders of small biotech firm Neothetics (NASDAQ:NEOT) got burned in a big way when lead candidate LIPO-202 flunked dual phase 3 trials roughly a year ago.
NEOT data by YCharts
LIPO-202 is an injectable formulation of salmeterol xinafoate, a well-known long-acting 2-adrenergic receptor agonist used in several FDA-approved drugs. It was indicated for the reduction of central....More>>>
Our newest recommendation offers consumer-oriented health benefit plans and services for a wide range of customers, explains Nicholas Vardy, editor of Vardy’s Alpha Algorithm.
UnitedHealth Group (UNH) also provides Medicaid plans, health care programs and health services through a network of one million physicians and healthcare professionals at some 6,000 hospitals and other facilities.
Wall Street analysts tend to be a bullish lot, and few have been as bullish as FundStrat’s Thomas Lee, who’s been accused of being a perma-bull. But just as his colleagues seem to be embracing another year of gains, Lee has decided to dial back the optimism. In his 2017 outlook released today, Lee wrote that he expects that S&P 500 to finish the year at 2,275, down a few points from....More>>>
Won’t $0.99 per gallon of gasoline be great? That is what some “experts” predict for the summer of 2016. Maybe it will happen; maybe it won’t. What is for sure is that the price of oil has collapsed over the past year, and many U.S. oil companies have gone out of business.
Stocks have inched positive after the minutes from July’s FOMC meeting showed the Fed in no apparent rush to hike interest rates.
The S&P 500 has ticked up 0.1% to 2,179.41 at 2:20 p.m. today, while the Dow Jones Industrial Average has advanced 8.87 points, or 0.1%, to 18,560.89. The Nasdaq Composite has declined 0.1% to 5,224.62.
Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent....More>>>
NewmontMining Corp. (NYSE: NEM) reported fourth-quarter and full-year 2016 earnings after markets closed Tuesday. For the quarter, the gold miner posted adjusted earnings per share (EPS) of $0.25 on revenues of $1.79 billion. In the same period a year ago, the company reported a loss per share of $0.03 on revenues of $1.82 billion. Fourth-quarter results compare to the Thomson Reuters consensus....More>>>
New York, NY, based Investment company Grandfield & Dodd, Llc buys Enbridge, Johnson Controls International PLC, M&T Bank, Albemarle, Walt Disney Co, Gilead Sciences, US Bancorp, Abbott Laboratories, Vanguard Large-Cap ETF – DNQ, Clorox Co, sells Spectra Energy, St Jude Medical, Nordstrom, Emerson Electric Co, Chubb during the 3-months ended 2017-03-31, according to the most recent....More>>>
A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business....More>>>
Our Long Idea reports aim to identify those firms that the market has overlooked and that, when analyzed beyond standard metrics, are significantly undervalued. These hidden gems provide excellent upside potential to any portfolio, with little downside risk.
In addition to individual Long Ideas, we provide Model Portfolios that provide well-screened lists of companies based on specific criteria....More>>>
When buying a home, the most important numbers for mortgage lenders are the buyer’s credit score and the buyer’s debt-to-income ratio. The first is a summary of how the buyer has been managing debt and the second indicates whether the lender can reasonably expect the borrower to be